Kidney Cancer Journal shared on X:
“Just in Kidney Cancer Journal Excellent review by Albert Jang and Shilpa Gupta on papillary RCC.
Despite improved outcomes with VEGF-TKIs and ICIs, more dedicated clinical trials to pRCC are urgently needed”.
For more detailed information, read the article.
Source: Kidney Cancer Journal/X